79 related articles for article (PubMed ID: 23124104)
1. Injectable PLGA/hydrocortisone formulation produced by continuous supercritical emulsion extraction.
Falco N; Reverchon E; Della Porta G
Int J Pharm; 2013 Jan; 441(1-2):589-97. PubMed ID: 23124104
[TBL] [Abstract][Full Text] [Related]
2. PLGA microdevices for retinoids sustained release produced by supercritical emulsion extraction: continuous versus batch operation layouts.
Porta GD; Campardelli R; Falco N; Reverchon E
J Pharm Sci; 2011 Oct; 100(10):4357-67. PubMed ID: 21638283
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
Della Porta G; Reverchon E
Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
[TBL] [Abstract][Full Text] [Related]
4. NSAID drugs release from injectable microspheres produced by supercritical fluid emulsion extraction.
Della Porta G; Falco N; Reverchon E
J Pharm Sci; 2010 Mar; 99(3):1484-99. PubMed ID: 19780130
[TBL] [Abstract][Full Text] [Related]
5. Injectable PLGA/Hydroxyapatite/Chitosan Microcapsules Produced by Supercritical Emulsion Extraction Technology: An In Vitro Study on Teriparatide/Gentamicin Controlled Release.
Della Porta G; Campardelli R; Cricchio V; Oliva F; Maffulli N; Reverchon E
J Pharm Sci; 2016 Jul; 105(7):2164-72. PubMed ID: 27290629
[TBL] [Abstract][Full Text] [Related]
6. Continuous supercritical emulsions extraction: a new technology for biopolymer microparticles production.
Porta GD; Falco N; Reverchon E
Biotechnol Bioeng; 2011 Mar; 108(3):676-86. PubMed ID: 20967801
[TBL] [Abstract][Full Text] [Related]
7. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
8. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
9. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
10. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
[TBL] [Abstract][Full Text] [Related]
12. Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.
Yang X; Patel S; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2014 Jun; 15(3):569-87. PubMed ID: 24504495
[TBL] [Abstract][Full Text] [Related]
13. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
14. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
Doan TV; Olivier JC
Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
[TBL] [Abstract][Full Text] [Related]
15. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
16. Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method.
He J; Zhou Z; Fan Y; Zhou X; Du H
J Microencapsul; 2011; 28(8):763-70. PubMed ID: 22034953
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
D'Aurizio E; van Nostrum CF; van Steenbergen MJ; Sozio P; Siepmann F; Siepmann J; Hennink WE; Di Stefano A
Int J Pharm; 2011 May; 409(1-2):289-96. PubMed ID: 21356295
[TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
Doan TV; Couet W; Olivier JC
Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
[TBL] [Abstract][Full Text] [Related]
19. Novel Superparamagnetic Microdevices Based on Magnetized PLGA/PLA Microparticles Obtained by Supercritical Fluid Emulsion and Coating by Carboxybetaine-Functionalized Chitosan Allowing the Tuneable Release of Therapeutics.
Cricchio V; Best M; Reverchon E; Maffulli N; Phillips G; Santin M; Della Porta G
J Pharm Sci; 2017 Aug; 106(8):2097-2105. PubMed ID: 28499877
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
